New Two-Drug attack on tough prostate cancer
NCT ID NCT06228053
Summary
This study is testing whether adding an experimental drug called SX-682 to a standard prostate cancer drug (enzalutamide) can help men whose cancer has spread and stopped responding to other hormone therapies. The goal is to see if this combination can control the cancer's growth and extend survival. The trial will enroll about 53 men to measure how well the treatment works and monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University
RECRUITINGDurham, North Carolina, 27710, United States
Contact
Contact Email: •••••@•••••
-
University of California, Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact Email: •••••@•••••
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Email: •••••@•••••
Contact
-
University of Minnesota
NOT_YET_RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact Email: •••••@•••••
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53792, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.